Another European patient has contracted PML while on Tysabri. This would be the fifth patient to contract the brain infection since Tysabri has been reintroduced.

Of course, this was revealed in a financial article. Seems there's more interest in how this impacts the bottom line than how it impacts the patients on the drug.

Despite the news, Tysabri has still done wonderful things for many patients. I sure wish it had helped me...

http://www.reuters.com/article/busin...e=businessNews